Sphingolipids (sphingomyelin, glycolipids, gangliosides) are located in cell membranes, plasma, and lipoproteins. In patients with cardiovascular, renal, and metabolic diseases, the profile of sphingolipids and their metabolites (ceramide, sphingosine, and sphingosine-1-phosphate) is modified, and these changes may explain the alterations in some cellular responses such as apoptosis. Furthermore, sphingosine and sphingosine-1-phosphate have been suggested to prevent COVID-19. This review also briefly mentions the techniques that allow us to study sphingolipids and their metabolites.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161840 | PMC |
| http://dx.doi.org/10.24875/ACM.21000333 | DOI Listing |
Publication Analysis
Top Keywords
cardiovascular renal
8
renal metabolic
8
metabolic diseases
8
sphingolipids metabolites
8
sphingosine sphingosine-1-phosphate
8
sphingolipid metabolism
4
metabolism relationship
4
relationship cardiovascular
4
diseases sphingolipids
4
sphingolipids sphingomyelin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!